Insider · CIK 0001846905
Muna Bhanji
Files at CYTK (CYTOKINETICS INC), VCYT (VERACYTE, INC.), ARDX (ARDELYX, INC.), NTLA (Intellia Therapeutics, Inc.). First filing Jan 31, 2025, latest Sep 3, 2026.
Where the trades landed
Last year at the 3 companies this insider has traded most, with each buy and sell on the bar it happened.
VCYT: VERACYTE, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
NTLA: Intellia Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
CYTK: CYTOKINETICS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | VERACYTE, INC. | $80k 1,864 shares | -4% | +45% from low-28% from high | |
| 25Weak | VERACYTE, INC. | $122k 4,589 shares | -13% | 0% from low-43% from high | |
| 16Weak | CYTOKINETICS INC | $43k 1,454 shares | -6% | 0% from low-49% from high | |
| 0Weak | Intellia Therapeutics, Inc. | $2,253 265 shares | -1% | +31% from low-64% from high | |
| 0Weak | Intellia Therapeutics, Inc. | $2,642 265 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | VCYT VERACYTE, INC. | SOpen-market sale Common Stock10b5-1 | -1,864 | $42.97 | $80k | 42,718 | 39 d ago |
| Jun 18, 2025 | ARDX ARDELYX, INC. | AGrant or award Common Stock | +41,551 | $0.00 | $0 | 137,353 | Jun 23, 2025 |
| Jun 18, 2025 | VCYT VERACYTE, INC. | AGrant or award Common Stock | +9,321 | $0.00 | $0 | 39,310 | Jun 23, 2025 |
| Jun 18, 2025 | ARDX ARDELYX, INC. | AGrant or award Stock Option (Right to Buy)derivative | +54,059 | $0.00 | $0 | 54,059 | Jun 23, 2025 |
| Jun 13, 2025 | VCYT VERACYTE, INC. | SOpen-market sale Common Stock10b5-1 | -4,589 | $26.67 | $122k | 29,989 | Jun 17, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 27,203 | Jun 13, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,450 | $0.00 | $0 | 11,450 | Jun 13, 2025 |
| May 15, 2025 | CYTK CYTOKINETICS INC | SOpen-market sale Common Stock10b5-1 | -1,454 | $29.73 | $43k | 23,510 | May 15, 2025 |
| May 14, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +7,333 | $0.00 | $0 | 24,964 | May 14, 2025 |
| May 14, 2025 | CYTK CYTOKINETICS INC | AGrant or award Non-Qualified Stock Option (Right to Buy)derivative | +10,880 | $0.00 | $0 | 10,880 | May 14, 2025 |
| Apr 29, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -265 | $8.50 | $2,253 | 19,203 | May 1, 2025 |
| Jan 29, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -265 | $9.97 | $2,642 | 19,468 | Jan 31, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.